Altimmune, Inc. (ALT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Altimmune, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.61x | -5.39x | -6.77x | -9.11x | -3.89x | -5.90x |
| P/B Ratio | 1.41x | 4.14x | 3.09x | 4.17x | 1.90x | 1.28x |
| P/S Ratio | 7757.46x | 25596.73x | 1406.17x | -11352.04x | 85.75x | 35.33x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -309.4% |
| Operating Margin | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.6% | -669.5% |
| Net Margin | -214861.0% | -475295.0% | -20762.2% | 124577.9% | -2201.6% | -599.2% |
| EBITDA Margin | -212258.5% | -474060.0% | -20642.0% | 124130.9% | -2189.0% | -465.5% |
| Liquidity | ||||||
| Current Ratio | 18.55x | 13.11x | 17.26x | 11.31x | 11.17x | 19.16x |
| Quick Ratio | 18.55x | 13.11x | 17.26x | 11.31x | 11.17x | 19.16x |
| Leverage | ||||||
| Debt/Equity | 0.16x | 0.01x | 0.00x | 0.01x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..